Akme fintrade IPO GMP Today, Akme fintrade Grey Market Premium

Akme fintrade IPO Allotment Status Online

Durlax Top Surface IPO GMP Today in the Grey Market is Not Available at The Moment. Investors are Advised to Closely Monitor Market Trends and consult Reliable Sources for the Most up-to-date Information. It is important to Exercise Caution and Conduct Thorough Research Before Making Any Investment Decisions.

About Akme fintrade IPO-

How Much GMP Price Akme fintrade IPO today?, live Grey Market Premium Kostak Rates today live Akme fintrade IPO Now. Subject to sauda Rate today, Akme fintrade IPO as of today Subject to sauda rates kostak.

Akme fintrade IPO is to open on 19 June, 2024. Akme fintrade is a Mainline IPO to Raise 11,000,000 shares (Approx ₹132.00 Cr) Via IPO. The Akme fintrade IPO Price Band is Fixed At ₹120 Per Every Share With a IPO Lot Size of 125 Shares.


About Akme fintrade Data Like –
  • Nirmal Kumar jain is the CEO of Akme fintrade and Akme fintrade was founded in the year 1996 and has just completed 28 years in operation.
  • Akme fintrade have a long history of serving rural and semi-urban markets with high growth potential and have maintained a track record of financial performance and operational efficiency through consistently high rates of customer acquisition and retention and low cost expansion into underpenetrated areas. Therefore, we strategically focus on clients in the rural and semiurban sector.
  • Our IT team is actively engaged in developing the product for loan against property, commercial vehicle financing, and secured business loans, We have our footprints in rural and semi-urban geographies in 4 Indian states Rajasthan, Maharashtra, Madhya Pradesh and Gujarat through registered office located at Udaipur, Rajasthan.

Akme fintrade IPO GMP With Per Lot Profit

26 June ₹17 ₹137
25 June ₹17 ₹137
24 June ₹20 ₹140
23 June ₹32 ₹152
22 June ₹32 ₹152
21 June ₹32 ₹152
20 June ₹32 ₹152
19 June ₹50 ₹170
18 June ₹42 ₹162
17 June ₹32 ₹152
16 June ₹32 ₹152
15 June ₹32 ₹152
14 June ₹32 ₹152
13 June ₹0 ₹0


Also Read : Akme fintrade IPO details IPO Date, Price, GMP, Review, Details


Latest IPO GMP

We Update live GMP status of all upcoming IPOs every day until the IPO gets listed on the stock exchange. You can easily see the GMP price of all IPOs on our IPO GMP dashboard. We update IPO GMP performance regularly on Moneymintidea.com. You can easily get a rough idea of the GMP of all IPOs and what the listing price of the IPO is going to be.

IPO Grey Market Premium (GMP) 

Before investing money in any IPO, one should pay more attention to the fact that the IPO GMP price is very volatile, if you are thinking of investing in Akme fintrade IPO by looking at the GMP price, then your decision may prove to be quite risky. Before investing in a new IPO, you should have good knowledge about the business of the company. It should be your decision whether to invest in Akme fintrade IPO or not and not by looking at the GMP price of the IPO.

Grey Market Premium (GMP) is the price at which an IPO is traded in an informal/unregulated manner before getting listed on the stock exchange. GMP price in the gray market reflects the price at which a company’s IPO is listed. Going to do. A good GMP premium/price gives you an indication of how much profit the IPO will make upon listing. Rather, if the GMP premium of an IPO is negative, then one should avoid investing money in that IPO.

Disclaimer:- The article here should not be construed as an offer to you to buy or sell based on any IPO / Gray Market Premium (GMP) or as advice in any way. The article here is written for informational and educational informational purposes only. This article should not be relied upon for investing in IPOs. Readers should consult a qualified financial advisor before making investment decisions.

Any reader making any investment decision based on the information published here does so entirely at his own risk. Investors should be aware that any investment in the equity market is subject to unpredictable market-related risks. The author does not intend to invest in this offering.

Leave a Comment